×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRSN – neurosense therapeutics ltd. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRSN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
09:26 am
nrsn
NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND [Yahoo! Finance]
Medium
Report
NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND [Yahoo! Finance]
11/21
09:20 am
nrsn
NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND
Medium
Report
NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND
10/28
08:30 am
nrsn
NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission
Medium
Report
NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission
10/28
08:01 am
nrsn
EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission [Yahoo! Finance]
Low
Report
EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission [Yahoo! Finance]
10/24
08:30 am
nrsn
New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients
Medium
Report
New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients
10/15
09:15 am
nrsn
NeuroSense Advances Plans for Early Commercialization of Groundbreaking ALS Treatment in Canada, Provides Further Updates
High
Report
NeuroSense Advances Plans for Early Commercialization of Groundbreaking ALS Treatment in Canada, Provides Further Updates
10/9
09:00 am
nrsn
NeuroSense Therapeutics Plans to File for Early Commercialization of ALS Treatment in Canada
Medium
Report
NeuroSense Therapeutics Plans to File for Early Commercialization of ALS Treatment in Canada
10/7
09:00 am
nrsn
NeuroSense Therapeutics Announces Acceptance of Two PrimeC Abstracts at the 2024 NEALS Annual Meeting
Low
Report
NeuroSense Therapeutics Announces Acceptance of Two PrimeC Abstracts at the 2024 NEALS Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/22
04:31 pm
nrsn
Form 424B3 NeuroSense Therapeutics
Low
Report
Form 424B3 NeuroSense Therapeutics
11/19
04:16 pm
nrsn
Form F-1 NeuroSense Therapeutics
High
Report
Form F-1 NeuroSense Therapeutics
11/12
09:49 am
nrsn
Form 6-K NeuroSense Therapeutics For: Nov 12
Low
Report
Form 6-K NeuroSense Therapeutics For: Nov 12
10/31
05:00 pm
nrsn
Form 6-K NeuroSense Therapeutics For: Oct 31
Low
Report
Form 6-K NeuroSense Therapeutics For: Oct 31
10/30
09:45 am
nrsn
Form 6-K NeuroSense Therapeutics For: Oct 30
Low
Report
Form 6-K NeuroSense Therapeutics For: Oct 30
10/28
08:35 am
nrsn
Form 6-K NeuroSense Therapeutics For: Oct 28
Medium
Report
Form 6-K NeuroSense Therapeutics For: Oct 28
10/24
08:30 am
nrsn
Form 6-K NeuroSense Therapeutics For: Oct 24
Low
Report
Form 6-K NeuroSense Therapeutics For: Oct 24
10/15
09:36 am
nrsn
Form 6-K NeuroSense Therapeutics For: Oct 15
High
Report
Form 6-K NeuroSense Therapeutics For: Oct 15
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: